Millipore Sigma Vibrant Logo

SCC426 HCC827 GR6 Human Lung Adenocarcinoma Cell Line

HCC827 GR6 is thus a relevant cellular model for studying resistance mechanisms for EGFR/ERBB-targeted therapeutics.

View Products on Sigmaaldrich.com
SCC426
≥1X10⁶ cells/vial   
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberSCC426
      DescriptionHCC827 GR6 Human Lung Adenocarcinoma Cell Line
      OverviewLung cancer is the most common cause of cancer-related death worldwide. The major etiological factor of lung cancer is tobacco smoke, a complex mixture of many carcinogens that play a role in the genetic and epigenetic changes occurring in the respiratory
      Background InformationHCC827 GR6 human lung adenocarcinoma cell line is a model for gefitinib-resistant non-small cell lung cancer. Lung cancer is the most common cause of cancer-related death worldwide. Tobacco smoke, the main causal factor of lung cancer, is a complex mixture of many carcinogenic agents that effect genetic and epigenetic mutations in the respiratory epithelium during carcinogenesis.1Patient outcome depends on multiple factors, including the genomic signature of the tumor, and these factors help to identify patients most likely to benefit from targeted therapeutics. Patients with or EGFR (epidermal growth factor receptor, a tyrosine kinase) - activating mutations have a higher likelihood to respond to first-generation EGFR-targeted tyrosine kinase inhibitors such as erlotinib and gefitinib; however, Intrinsic or acquired resistance often limits the efficacy of targeted therapies. Resistance most often arises through secondary mutations in EGFR or amplification of the MET oncogene.2
      The lung adenocarcinoma HCC827 is non-small cell lung cancer (NSCLC) cell line with an acquired E746-A750 deletion in the EGFR tyrosine kinase exon 19 domain.1 HCC827 has been used extensively in biomedical discovery and research. HCC827 GR6 is a gefitinib-resistant clone of the parental gefintinib-hypersensitive HCC827 cell line developed by six-month exposure to increasing concentrations of gefitinib in vitro.2 The resistance was shown to be a result of focal amplification of the MET proto-oncogene. Inhibition of MET signaling restores sensitivity of these cells to gefitinib. HCC827 GR6 is thus a relevant cellular model for studying resistance mechanisms for EGFR/ERBB-targeted therapeutics.

      Source
      HCC827 GR6 human lung adenocarcinoma cell line was derived from clonally isolated single cells of the parental HCC827 cell line. The parental cell line was isolated from non-small cell lung cancer tissue of a 39-year old female patient.1

      References
      1. Girard L, Zöchbauer-Müller S, Virmani AK, Gazdar AF, Minna JD. Cancer Res 2000; 60(17): 4894-4906.
      2. Engelman JA et al. Science 2007; 316(5827): 1039-1043.
      References
      Product Information
      Applications
      ApplicationHCC827 GR6 is thus a relevant cellular model for studying resistance mechanisms for EGFR/ERBB-targeted therapeutics.
      Key Applications
      • Cell Culture
      Application NotesThis product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
      Biological Information
      Cell Line Type
      • Cancer Cells
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEach vial contains ≥1X10⁶ cells/vial viable cells.

      Cells are tested negative for infectious diseases by a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.

      Cells are verified to be of human origin and negative for inter-species contamination from mouse, rat, Chinese hamster, Golden Syrian hamster, and Non-human Primate (NHP) as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services

      Cells are negative for mycoplasma contamination.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsCells should be stored in liquid nitrogen until use. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
      Packaging Information
      Material Size≥1X10⁶ cells/vial
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      SCC426 04065266515657